China In-Focus Weekly Round-Up

November 7, 2009 (FinancialWire) — “China In-Focus” news last week included China Medicine Corp. (OTCBB: CHME) and Actions Semiconductor Co., Ltd. (NADAQ: ACTS):

Chen Named CEO Of Actions Semiconductor:  Actions Semiconductor Co., Ltd. (NADAQ: ACTS) has promoted Niccolo Chen, its chief strategy officer and general manager, to the position of chief executive officer. He replaces Nan-Horng Yeh, who is stepping down from this position to pursue personal interests. Yeh will remain an Actions board member. Additionally, the board appointed Robin… (continued at http://www.financialwire.net/2009/11/06/china-in-focus-chen-named-ceo-of-actions-semiconductor/).

China Medicine To Buy Sinoform:   China Medicine Corp. (OTCBB: CHME) has signed an equity transfer agreement to acquire 100% of equity interests in Sinoform Ltd., a British Virgin Islands firm and the sole shareholder of Guangzhou LifeTech Pharmaceuticals Co. Ltd. LifeTech is a developer, manufacturer and marketer of pharmaceuticals products and TC. Under the terms of a… (continued at http://www.financialwire.net/2009/11/02/china-medicine-to-buy-sinoform/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site  (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).